Paving the Way Towards Universal Chimeric Antigen Receptor Therapy in Cancer Treatment: Current Landscape and Progress

Chimeric antigen receptor (CAR) therapy has been proved effective in a stream of clinical trials, especially in hematologic malignancies. However, current CAR therapy is highly personalized as cells used are derived from patients themselves, which can be costly, time-consuming, and sometimes fails t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yixi, Li, Pan, Fang, Hongyu, Wang, Guocan, Zeng, Xun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7758418/
https://www.ncbi.nlm.nih.gov/pubmed/33362790
http://dx.doi.org/10.3389/fimmu.2020.604915

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7758418/
https://www.ncbi.nlm.nih.gov/pubmed/33362790
http://dx.doi.org/10.3389/fimmu.2020.604915

Ejemplares similares